BlackRock Inc. - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 28 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$119,000
-38.7%
232,614
+11.7%
0.00%
Q4 2018$194,000
-43.6%
208,178
+7.9%
0.00%
Q3 2018$344,000
+29.3%
192,902
+2.1%
0.00%
Q2 2018$266,000
-0.7%
188,961
+6.5%
0.00%
Q1 2018$268,000
-24.7%
177,408
+0.5%
0.00%
Q4 2017$356,000
-14.6%
176,561
+2.5%
0.00%
Q3 2017$417,000
-12.2%
172,217
+3.5%
0.00%
Q2 2017$475,000166,4280.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 169,901$411,0000.03%
Benin Management CORP 14,300$35,0000.01%
Northeast Financial Consultants Inc 15,000$36,0000.01%
WEDBUSH SECURITIES INC 25,500$62,0000.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 49,167$119,0000.00%
Renaissance Technologies 344,299$833,0000.00%
WELLS FARGO & COMPANY/MN 8,238$20,0000.00%
NORTHERN TRUST CORP 47,859$116,0000.00%
GROUP ONE TRADING, L.P. 28$00.00%
GEODE CAPITAL MANAGEMENT, LLC 146,083$353,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders